WebJun 27, 2024 · The nitrogenous heterocyclic compound was also found to suppress the expression of circRNAs circUBAP2, circZNF292, circHIPK3, circTCF25, and circCdr1, as well as lncRNAs H19, DQ786243, HOXD-AS1, CCAT1, and HULC, while it increased the expression of circRNAs circZKSCAN1, circMTO1, and circITCH, as well as lncRNAs … WebFeb 13, 2024 · Abstract. Retraction: ‘MicroRNA-206 upregulation relieves circTCF25-induced osteosarcoma cell proliferation and migration', by Yongkun Wang, Shaomin Shi, …
An update on the roles of circular RNAs in osteosarcoma - PMC
WebCircTCF25. The first discovery of circTCF25 is the carcinogenic cyclic RNA in bladder cancer. 20 Functionally, the higher expression of circTCF25 promotes the proliferation, migration, and invasion of osteosarcoma cells, accompanied by the corresponding changes of phenotype-related proteins (up-regulation of CyclinD1 and Cdk6 to increase cell ... WebAug 3, 2016 · The circTCF25 promotes proliferation and migration of bladder cancer cells via circTCF25-miR-103a-3p/miR-107-CDK6 pathway. ( A ) The sketch of structure of … immaterial in hindi
Downregulation of hsa_circ_0000285 serves as a prognostic …
WebApr 18, 2024 · The hsa_circ_0005075 expression correlated with HCC tumor size and showed good diagnostic potential. 25 Subsequently, Zhong et al used microarray assay to screen circRNA expression profiles of bladder carcinoma and predicted that circTCF25 could downregulate miR-103a-3p and miR-107, increase CDK6 expression and promote … WebFeb 13, 2024 · Our study aimed to unravel whether circTCF25 dictates cellular activities of osteosarcoma cells and address the possible mechanisms associated with microRNA (miR). circTCF25 and miR‐206 in clinical specimens from 25 patients suffering from osteosarcoma were quantified by quantitative reverse transcription‐polymerase chain reaction … WebCircRNA-associated-mTOR can regulate the progression and therapy of a variety of cancers in multiple signaling pathways, such as phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt)/mTOR, mitogen-activated protein kinase (MAPK)/mTOR, and AMP-activated protein kinase (AMPK)/mTOR axis. immaterial in law